苏州丰倍生物科技股份有限公司首次公开发行股票并在主板上市发行结果公告

Core Points - The application for the initial public offering (IPO) of Suzhou Fengbei Biotechnology Co., Ltd. has been approved by the Shanghai Stock Exchange and registered by the China Securities Regulatory Commission [1][2] - The IPO price is set at 24.49 yuan per share, with a total issuance of 35.9 million shares, all of which are new shares [2][3] - The strategic placement accounts for 20% of the total issuance, with the final strategic placement amounting to 11.37% after adjustments [3][4] Issuance Details - The issuance combines strategic placement, offline pricing for qualified investors, and online issuance for public investors [2] - The final number of shares for offline issuance is 7,601,703, while online issuance amounts to 24,215,000 shares [4][8] - The overall subscription rate for online issuance reached 8,814.92 times, prompting a mechanism to adjust the allocation between offline and online investors [3][4] Subscription Statistics - Total shares subscribed by online investors: 24,089,076 shares, with a total subscription amount of approximately 589.94 million yuan [8] - Total shares subscribed by offline investors: 7,601,703 shares, with a total subscription amount of approximately 186.17 million yuan [9] - No shares were abandoned by offline investors, while online investors abandoned 125,924 shares [8][9] Lock-up Period and Underwriting - Offline investors are subject to a lock-up period of 6 months for 10% of their allocated shares [10] - The underwriter, Guotai Junan Securities, will underwrite all shares that were abandoned during the subscription process, totaling 125,924 shares [11][12] Issuance Costs - Total issuance costs amount to approximately 84.75 million yuan, including underwriting fees, audit fees, legal fees, and other expenses [13]